Boule Diagnostics AB (CHIX:BOULs)
kr 26.3 (0%) Market Cap: 147.57 Mil Enterprise Value: 351.07 Mil PE Ratio: 0 PB Ratio: 0.86 GF Score: 47/100

Q4 2025 Boule Diagnostics AB Earnings Call Transcript

Feb 11, 2026 / 09:00 AM GMT
Release Date Price: kr26.3

Key Points

Positve
  • Boule Diagnostics AB (OSTO:BOUL) reported a 3rd consecutive quarter of positive operating cash flow, reflecting improved operational discipline and working capital management.
  • Gross margin improved year on year by 3.5 percentage points, supported by a more favorable product and geographical mix.
  • The company inaugurated a new headquarters in Sweden, strengthening its operational platform and supporting future growth.
  • Service performance improved materially, turning profitable for the first time, reflecting improved efficiency, scale, and cost discipline.
  • Boule Diagnostics AB (OSTO:BOUL) was selected as one of the top three preferred hematology providers in a nationwide tender in Italy, reinforcing product quality and trust with large institutional customers.
Negative
  • Q4 sales were down organically by 11.7%, primarily due to lower instrument sales from the planned transition to licensed manufacturing in India.
  • The company faced a 4.3% unfavorable currency impact due to a weakened US dollar, affecting sales and gross profit.
  • Gross profit decreased from SEK63.8 million to SEK57.8 million due to lower sales and currency headwinds.
  • Operating profit was lower than last year, mainly due to lower gross profit and the expensing of R&D costs.
  • The company experienced challenges in collections from some parts of the world, holding back cash flow by about SEK6 million in the quarter.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BOUL.ST - Boule Diagnostics AB
Q4 2025 Boule Diagnostics AB Earnings Call
Feb 11, 2026 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everybody and welcome to the 4th quarter's earnings call for Bull Diagnostics. I'm Jorge Lambert, CFO for Bull Agnostics. With me, I have our CEO Thorbe Nielsen, and after our presentation, we will open up for questions. Please also feel free to write questions in the chat field. With that, I'm handing over to our CEO Thorbe Nielsen.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Holger.

Good morning everybody.

The 4th quarter brought a challenging market environment with currency headwinds from a weakened US dollar and lower instrument
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot